Respiratory Medicine
Volume 100, Issue 8 , Pages 1384-1391 , August 2006

Asthma and allergy in alpha-1 antitrypsin deficiency

  • Edward Eden

      Affiliations

    • Department of Pulmonary and Critical Care Medicine, St. Luke's Roosevelt Hospital, Columbia University, New York, NY, USA
    • Corresponding Author InformationCorresponding author. Tel.: +12125237341; fax: +12125238426.
  • ,
  • Charlie Strange

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Allergy and Asthma, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
  • ,
  • Brian Holladay

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Allergy and Asthma, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
  • ,
  • Lianqi Xie

      Affiliations

    • Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA

Received 12 August 2005 ,Accepted 22 November 2005.

References 

  1. ATS/ERS Statement: Standards for the Diagnosis and Management of Individuals with alpha-1 Antitrypsin Deficiency. Lung disease section. Am J Respir Crit Care Med. 2002;168:823–849
  2. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha1-antitrypsin deficiency: results of a survey. Cleveland Clin J Med. 1994;61:461–467
  3. Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Wong Lee W, et al. The lung health study. Airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis. 1992;145:300–310
  4. Hospers JJ, Schouten JP, Weiss ST, Rijcken B, Postma DS. Asthma attacks with eosinophilia predict mortality from COPD in a general population sample. Am J Respir Crit Care Med. 1999;160:1869–1874
  5. Silverstein MD, Reed CE, O’Connell EJ, Melton JL, O’Fallon WM, Yunginger JW. Long-term survival of a cohort of community residents with asthma. N Engl J Med. 1994;331:1537–1541
  6. Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist S, et al. Asthma features in severe alpha-1 antitrypsin deficiency. Experience of the NHLBI Registry. Chest. 2003;123:765–771
  7. Dowson LJ, Guest PJ, Stockley RA. Longitudinal changes in physiological, radiological and health status measurements in alpha-1 antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med. 2001;164:1805–1809
  8. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15 year follow up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194–1200
  9. Suppli Ulrik C, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med. 1994;150:629–634
  10. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126:59–65
  11. Lapperre TS, Snoeck-Stroband JB, Margot ME, et al. Dissociation of lung function and airways inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:499–504
  12. Prados M, Monteseirin FJ, Carranco MI, Aragon R Conde A, Conde J. Phenotypes of alpha-1 antitrypsin in intrinsic asthma and ASA-triad patients. Allergol Immunopathol Madr. 1995;23:24–28
  13. Eden E, Mitchell D, Mehlman B, Khouli H, Nejat M, Grieco MH, et al. Atopy, asthma and emphysema in patients with severe alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 1997;156:68–74
  14. The Alpha-1 Antitrypsin Deficiency Study Group. Survival and FEV1 decline in individuals with severe deficiency of Alpha-1 antitrypsin. Am J Respir Crit Care Med. 1998;158:49–59
  15. Anthonisen NR Wright EC and the IPPB Trial Group. Chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133:814–819
  16. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Jianfeng Xu MS, Panhuysen CIM, et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med. 1995;333:894–900
  17. Malerba M, Radaeli A, Ceriani L, Tantucci C, Grassi V. Airway hyperresponsiveness in a large group of subjects with alpha-1 antitrypsin deficiency: a cross-sectional study. J Int Med. 2003;253:351–358
  18. Soriano JB, Kourtney JD, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease. Two approximations from the United States and the United Kingdom. Chest. 2003;124:474–481
  19. Piitulainen E, Sveger T. Respiratory symptoms and lung function in young adults with severe alpha-1 antitrypsin deficiency (PiZZ). Thorax. 2002;57:705–708
  20. Dodge R, Cline MG, Burrows B. Comparisons of asthma, emphysema and chronic bronchitis diagnoses in a general population sample. Am Rev Respir Dis. 1986;133:981–986

PII: S0954-6111(05)00507-X

doi: 10.1016/j.rmed.2005.11.017

Respiratory Medicine
Volume 100, Issue 8 , Pages 1384-1391 , August 2006